| Prev Close | 98.88 |
| Day Low/High | 97.42 / 100.58 |
| 52 Wk Low/High | 76.34 / 186.82 |
Reata Pharmaceuticals, Inc. Class A (RETA)
98.36
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 36.39B |
| Market Cap | 3.60B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Monday's a Mixed Bag on the Market, Now Eyes Are on Iowa Caucuses
Tesla rocketed higher in a move similar to the bubble days of 20 years ago.
I'm Seeing Quite a Bit of Good Action in Individual Stocks
The bulls are hoping that this dead cat bounce transitions into a V-shaped bounce.
Trade With Your Cup Half Full
I learned from Jim Cramer long ago to focus on what can go right if you want to ride the momentum of stocks.
2 Promising Biotech Stocks That Insiders Are Snapping Up
Shares of Iovance Biotherapeutics and Reata Pharmaceuticals took it on the chin in the fourth quarter, but both companies seem ready to reward shareholders for their patience.
Here's a Handful of Small Biotechs Where Insiders Are Buying
Quotient Limited, Iovance Biotherapeutics and AVEO Pharmaceuticals are among the names seeing insider purchases.
2 Key 'Rules' When Investing in Biotech Stocks
Remembering these 'rules of the road' is vital in this highly volatile space.
Biotech Stocks Getting Their Due Respect
Here are two I think will bounce back before the end of the year.
How I Invest In Biotech Stocks
Here's two 'rules of the road' when investing in this highly volatile space.
3 Good Bargain Stocks With Insider Buying
I continue to keep a 'shopping list' at the ready for the next dip in the market.
The January Effect Is on Time This Year
I continue to believe that biotech and biopharma stocks will outperform in 2018.
Seeing the Same Old Patterns Ahead of Fed News
Buyers expect a dovish Fed and are still trying to put money to work.
Bounce Has Gone Bust Pretty Quickly
If the market closes weak today, it will be marked with an exclamation point.
